Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: Sample Handling in Microbiological Testing – V 2.0

Posted on By

Analytical Method Development: Sample Handling in Microbiological Testing – V 2.0

Standard Operating Procedure for Sample Handling in Microbiological Testing during Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/132/2025
Supersedes SOP/AMD/132/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP outlines the procedure for handling samples intended for microbiological testing in analytical method development, ensuring aseptic technique, chain of custody, appropriate storage,

and compliance with GMP and GLP practices.

2. Scope

This SOP applies to all microbiological samples received in the Analytical Method Development (AMD) laboratory for routine testing, validation, environmental monitoring, sterility assessment, and preservative efficacy studies.

3. Responsibilities

  • Microbiologist: Receives and documents the sample, performs integrity checks, and executes testing as per approved method.
  • Analytical Scientist: Ensures proper labeling and transfer of samples from production or R&D units.
  • QA Officer: Reviews sample traceability, storage records, and compliance with regulatory standards.
  • Head – AMD: Verifies sample chain of custody and ensures that the handling procedure is followed rigorously.
See also  Analytical Method Development: Apparatus Selection for Dissolution - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for maintaining the quality and integrity of all microbiological samples throughout the handling and testing lifecycle.

5. Procedure

5.1 Sample Receipt and Verification

  1. Ensure all samples are received in clean, leak-proof, and sterile containers with tamper-evident seals.
  2. Verify sample labeling: Sample ID, product name, batch number, date of collection, collected by, and test requested.
  3. Cross-check the sample request form (SRF) with the physical sample.
  4. Record details in Annexure-1: Sample Receipt Log.

5.2 Labeling and Identification

  1. Assign a unique lab sample code using the format: MB/YY/XXX (e.g., MB/25/031).
  2. Label each container with the assigned code using waterproof marker or pre-printed barcoded label.
  3. Update internal sample tracking system/database.

5.3 Storage of Samples

  1. Store samples under appropriate conditions:
    • Refrigerated (2–8°C) for preservative efficacy and microbial limit testing
    • Ambient (15–25°C) for water and surface swab samples
    • Frozen (−20°C or −80°C) for long-term reference storage (if required)
  2. Log storage location in Annexure-2: Sample Storage Record.
See also  Analytical Method Development: Derivatization Techniques in GC - V 2.0

5.4 Handling and Aseptic Technique

  1. Handle all samples within a certified laminar airflow workstation using aseptic techniques.
  2. Use sterile tools and wear appropriate PPE: gloves, gown, mask, and hair cover.
  3. Do not open or manipulate samples outside designated microbiological areas.
  4. Minimize handling time to reduce risk of contamination or degradation.

5.5 Sample Usage and Disposal

  1. Use only the required quantity for each test as per protocol.
  2. Record quantity drawn, date of testing, and analyst name in Annexure-3: Sample Usage Log.
  3. Dispose of unused or expired samples following the laboratory’s biohazard waste disposal policy.
  4. Update sample status as “Consumed,” “Retained,” or “Discarded.”

5.6 Chain of Custody and Documentation

  1. Ensure all steps from receipt to disposal are documented for traceability.
  2. In case of sample rejection (damaged, missing info, expired), log reason in Annexure-4: Sample Rejection Log.
  3. Retain all logs for a minimum of 5 years as per GMP documentation requirements.

6. Abbreviations

  • GMP: Good Manufacturing Practice
  • GLP: Good Laboratory Practice
  • SRF: Sample Request Form
  • AMD: Analytical Method Development
  • SOP: Standard Operating Procedure

7. Documents

  1. Sample Receipt Log – Annexure-1
  2. Sample Storage Record – Annexure-2
  3. Sample Usage Log – Annexure-3
  4. Sample Rejection Log – Annexure-4
See also  Analytical Method Development: SOP for Performing Precision Studies in Method Validation - V 2.0

8. References

  • WHO Technical Report Series 986 – GMP Guidelines
  • 21 CFR Part 211 – cGMP for Finished Pharmaceuticals
  • EU Annex 1 – Manufacture of Sterile Medicinal Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Sample Receipt Log

Date Sample ID Batch No. Received From Condition
18/05/2025 MB/25/031 B1234 Formulation R&D Acceptable

Annexure-2: Sample Storage Record

Sample ID Storage Location Temperature Stored By
MB/25/031 Micro Lab Fridge 1 2–8°C Rajesh Kumar

Annexure-3: Sample Usage Log

Date Sample ID Test Performed Quantity Used Analyst
19/05/2025 MB/25/031 MLT 5 mL Sunita Reddy

Annexure-4: Sample Rejection Log

Date Sample ID Reason for Rejection Action Taken
— — — —

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Updated to include barcode labeling and disposal traceability Annual Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: API Manufacturing: SOP for Control of Electronic QA Documentation – V 2.0
Next Post: Biosimilars: SOP for Tracking Consumables in Bioreactor Runs – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version